Skip to content

Stopping NNRTIs in drug-resistant patients does not alter viral loads or CD4 cell counts

Amprenavir levels boosted tenfold by delavirdine in children

The male genital tract is not a sanctuary site for HIV, argue Dutch researchers

HIV Drug Resistance Workshop: new concepts for the clinician

HIV Drug Resistance Workshop: population surveys of resistance

HIV Drug Resistance Workshop: prevention of mother to child transmission

HIV Drug Resistance Workshop: key take home messages

HIV Drug Resistance Workshop: Non-B HIV subtypes

HIV Drug Resistance Workshop: entry and attachment inhibitors

Occult hepatitis B infection present in 2% of HIV-positive patients in US study

Starting HAART soon after HIV infection leads to greater reduction in viral reservoir

HAART leads to fall in AIDS cancers in US women's study, but incidence of NHL still elevated

Cheap multivitamin slows time to AIDS and death in African women

Generic fixed-dose combination pill effective, safe, and of high quality, Lancet reports

GlaxoSmithKline grants voluntary licenses for AZT, 3TC, to second South African company

Boosted dual PI salvage regimen safe, effective but high pill burden an issue

Main article: Integrating HIV prevention and treatment

UK government announces £116m of extra HIV funding for UN agencies